Several Companies

 
News Articles for Several Companies top ^
2014/9/15
Chevron Products Company, a Chevron U.S.A. Inc. division, maker of the Delo ® brand of technologically advanced heavy duty engine oils, lubricants and coolants, today unveiled a new category of heavy duty motor oil designed to address the growth of severe duty applications in on- and off-highway markets.
Sign-up for Chevron Creates New Heavy Duty Category to Protect Engines in Severe Duty Operations investment picks
Results from Earlier Clinical Trials Published Today in the New England Journal of Medicine TARRYTOWN, N.Y. and PARIS , July 9, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) and Sanofi (EURONEXT: SAN and NYSE: SNY ) today announced positive results from a Phase 2b dose-ranging study of dupilumab, an investigational therapy, in adult patients with moderate-to-severe atopic dermatitis (AD), a serious, chronic form of eczema.
Sign-up for Regeneron and Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis investment picks
2014/8/5
Ophthotech Corporation announced today the initiation of the first of several planned expansion trials, in addition to the ongoing Fovista ® combination therapy Phase 3 clinical program.
Sign-up for Ophthotech Initiates First of Several Expansion Studies to Further Evaluate Fovista® (Anti-PDGF) Therapy in Patients with Wet Age-Related Macular Degeneration investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that its partner GlaxoSmithKline (GSK) plc has received approval of a supplemental New Drug Application (sNDA) for the once-daily use of Promacta ® /Revolade ™ (eltrombopag) in patients with severe aplastic anemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST). 1 SAA is a blood disorder where the bone marrow fails to make enough red blood cells, white blood cells and platelets.
Sign-up for Ligand Partner GlaxoSmithKline Receives U.S. FDA Approval for Promacta®/Revolade™ For Use in Patients with Severe Aplastic Anemia investment picks
PARIS and TARRYTOWN, N.Y., July 9, 2014 (GLOBE NEWSWIRE) -- Sanofi (EURONEXT : SAN and NYSE : SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive results from a Phase 2b dose-ranging study of dupilumab, an investigational therapy, in adult patients with moderate-to-severe atopic dermatitis (AD), a serious, chronic form of eczema.
Sign-up for Sanofi and Regeneron Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis investment picks
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that researchers presented new data from an integrated analysis of survival from two open-label, Phase 2 studies of asfotase alfa in pediatric patients (ages ≤5 years at enrollment) with hypophosphatasia (HPP) compared with data from a retrospective natural history study of untreated historical control patients matched for age and disease severity.
Sign-up for Improved Survival Observed in Pediatric Patients with Severe Hypophosphatasia (HPP) Who Were Treated with Investigational Asfotase Alfa for Up to Five Years investment picks
-- HUMIRA is now indicated to treat pediatric patients 6 years of age and older with moderately to severely active Crohn's disease who have had an inadequate response to corticosteroids or immunomodulators such as azathioprine, 6-mercaptopurine, or methotrexate --
Sign-up for AbbVie's HUMIRA® (adalimumab) Receives U.S. FDA Approval for the Treatment of Pediatric Patients with Moderately to Severely Active Crohn's Disease investment picks
Celgene Corporation (NASDAQ: CELG) today announced that the U.S. Food and Drug Administration (FDA) has approved OTEZLA® (apremilast), the Company’s oral, selective inhibitor of phosphodiesterase 4 (PDE4), for the treatment of patients with moderate to severe plaque psoriasis for whom phototherapy or systemic therapy is appropriate.
Sign-up for Oral OTEZLA® (apremilast) Approved by the U.S. Food and Drug Administration for the Treatment of Patients with Moderate to Severe Plaque Psoriasis investment picks
2014/9/9
ComEd is increasing its staffing and opening its Emergency Operations Center as of 5 a.m. Wednesday, in preparation for severe weather expected to enter its service territory.
Sign-up for ComEd Prepares for Severe Weather Expected to Hit Northern Illinois investment picks
2014/6/30
ComEd is increasing its staffing and opening its Emergency Operations Center as of 5 p.m. today, in advance of severe weather expected to enter its service territory.
Sign-up for ComEd Prepares for Severe Weather Expected to Hit Northern Illinois investment picks
2014/6/30
Kids at risk of severe allergies attend soccer clinic hosted by the Montreal Impact and Allerject™ Canada NewsWire MONTREAL , June 30, 2014 /CNW Telbec/ - For more than 75 youngsters with life-threatening allergies, participating in a soccer clinic hosted by the Montreal Impact and Allerject™ was a dream come true.
Sign-up for Kids at risk of severe allergies attend soccer clinic hosted by the Montreal Impact and Allerject™ investment picks
Mandalay Resources announces multiple high-grade drill intercepts on several veins and begins infill drilling at its Cerro Bayo Silver-Gold Mine, Chile Canada NewsWire TORONTO , July 9, 2014 /CNW/ - Mandalay Resources Corporation ("Mandalay" or the "Company") (TSX: MND) is pleased to announce encouraging results of its continuing wide-spaced core drilling program from underground and surface platforms to probe for vein extensions and has recognized two new veins under Laguna Verde (click here for Figure 1 - Laguna Verde Drill Plan View). Highlights of the results during the first half of 2014 include: Coyita vein ( Figure 2 and Table 1) — Thirteen new intercepts have defined the extension of the Coyita vein, establishing a strongly mineralized zone approximately 500 m along strike and at least 200 m down dip on the vein.
Sign-up for Mandalay Resources announces multiple high-grade drill intercepts on several veins and begins infill drilling at its Cerro Bayo Silver-Gold Mine, Chile investment picks
Assurant, Inc. (NYSE:AIZ), a premier provider of specialized insurance and insurance-related products and services, finalized the company’s 2014 Property Catastrophe Reinsurance Program to help safeguard more than 2.4 million property insurance policyholders in the event of damage from severe storms.
Sign-up for Assurant’s 2014 Property Catastrophe Reinsurance Program Provides Protection Against Severe Storms investment picks
2014/7/5
PECO has restored electric service to nearly all of the more than 155,000 customers left without electric service by Thursday’s severe thunderstorm.
Sign-up for PECO Restores Service to Nearly All Customers Affected by Thursday’s Severe Summer Storm investment picks
MILWAUKEE, July 22, 2014 /PRNewswire/ -- Briggs & Stratton Corporation (NYSE: BGG) , the exclusive licensee of GE Generator Systems, recently donated a GE Generator to severely wounded Marine, and Purple Heart recipient, John "JT" Doody thanks to the help of the Gary Sinise Foundation.
Sign-up for Gary Sinise Foundation and Briggs & Stratton Corporation Connect to Donate a GE Generator System to Severely Wounded Marine John "JT" Doody investment picks
2014/7/16
REXBURG, Idaho , July 16, 2014 /PRNewswire/ -- The U-Haul Company of Idaho is offering 30 days of free self-storage and U-Box portable moving and self-storage to people throughout Rexburg and Madison county who were affected by the recent heavy rains and severe flooding.
Sign-up for U-Haul Offering 30 Days of Free Self-Storage and U-Box Portable Moving and Self-Storage Pods to Idaho Residents Affected by Recent Heavy Rains and Severe Flash Flooding investment picks
- New first-in-class treatment option for this previously treated SAA patient population LONDON , Aug.
Sign-up for GSK receives FDA approval of an additional Promacta® (eltrombopag) indication for use in patients with severe aplastic anaemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST) investment picks
2014/9/3
http://media.marketwire.com/attachments/201408/TN-272580_M115XDLFHC.eps.jpg In case of inclement weather, lock up all possible outdoor belongings in a covered shed or garage, and secure the door with a padlock built to survive extreme weather situations, such as the Master Lock M115XDLF Covered Laminated Padlock.
Sign-up for Master Lock Helps Consumers Prepare for Severe Weather investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Several Companies
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Seven Companies  |  Next: Shale Assets